Goldman Sachs Curing Patients Business Model
INVESTING Goldman Sachs asks in biotech research report: ‘Is curing patients a sustainable business model?’ PUBLISHED WED, APR 11 2018·3:15 PM EDT UPDATED WED, APR 11 2018·7:20 PM EDT
A CNBC article screenshot shows Goldman Sachs questioning whether curing patients is a sustainable business model. The joke highlights the cynical conflict between healthcare profits and actually eliminating the need for treatment.
news article screenshot / скриншот новостной статьиheadline / заголовокbiotech research report / исследовательский отчёт о биотехнологияхCNBC website layout / макет сайта CNBCauthor portrait / портрет автораblue navigation bar / синяя панель навигацииred live button / красная кнопка прямого эфираsearch icon / значок поискаarticle text / текст статьиwhite webpage background / белый фон веб-страницы
- @right_wing_dev_squads / 11589 2025-02-25
- Type
- image
- Size
- 800×603 · 67.3 KiB
- Mood
- cynical, satirical
- Language
- en
- Added